We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TPC:NYSETutor Perini Corporation Analysis

Data as of 2026-09-01 - not real-time

$87.59

Latest Price

8/10Risk

Risk Level: High

Executive Summary

At $87.59, Tutor Perini Corporation shows a bullish moving-average alignment, with shorter averages sitting above longer ones. With RSI at 47.3 the momentum picture is neutral, alongside a bearish MACD signal. The recent range runs from support at $84.24 up to resistance at $102.30.
On valuation the read is fair — earnings multiple of 37.8 versus a 28.7 sector average, above the peer group. The average analyst target implies 32.7% above today's level. Revenue is growing at 19.2% on a 2.1% profit margin. The 0.41% dividend yield looks covered by current payout levels.
Risk comes out at 8 of a possible 10, a high reading. With 30-day volatility of 59.0%, a beta of 1.75 and a maximum drawdown of 29.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to buy, carrying 4/10 conviction.

Top Market Events

TPC posts record Q2 revenue and operating income, raises 2026 EPS guidance to $5.General contracting company Tutor Perini NYSE:TPC reported Q2 CY2026 results exceeding the market’s revenue...Tutor Perini NYSE:TPC subsidiary Perini Management Services Inc.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 78.12
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 37.8 versus sector average of 28.7
  • Trading above the 200-day average of 78.12

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • P/E of 37.8 versus sector average of 28.7
  • Analyst targets imply +32.7% versus the current price
  • Revenue growth of +19.2%

Key Metrics & Analysis

Financial Health

Revenue Growth19.20%
Profit Margin2.08%
P/E Ratio37.8
ROE13.74%
ROA3.29%
Debt/Equity34.82
Op. Cash Flow$796.9M
Free Cash Flow$573.2M
Industry P/E28.7

Technical Analysis

TrendBullish
RSI47.3
Support$84.24
Resistance$102.30
MA 20$92.25
MA 50$85.45
MA 200$78.12
MACDBearish
VolumeDecreasing
Fear & Greed Index94.05

Valuation

Fair Value$312.94
Target Price$116.25
Upside/Downside32.72%
GradeFair
TypeGrowth
Dividend Yield0.41%

Risk Assessment

Beta1.75
Volatility59.01%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.